• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006 年至 2017 年英格兰胆管癌诊断途径的地域差异。

Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017.

机构信息

Department of Analytics, Health Data Insight CIC, Cambridge CB21 5XE, United Kingdom.

National Disease Registration Service, NHS England, London E14 4PU, United Kingdom.

出版信息

World J Gastroenterol. 2023 Jun 28;29(24):3825-3842. doi: 10.3748/wjg.v29.i24.3825.

DOI:10.3748/wjg.v29.i24.3825
PMID:37426314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10324535/
Abstract

BACKGROUND

Incidence of cholangiocarcinoma (CCA) is rising, with overall prognosis re-maining very poor. Reasons for the high mortality of CCA include its late presentation in most patients, when curative options are no longer feasible, and poor response to systemic therapies for advanced disease. Late presentation presents a large barrier to improving outcomes and is often associated with diagnosis mergency presentation (EP). Earlier diagnoses may be made by Two Week Wait (TWW) referrals through General practitioner (GP). We hypothesise that TWW referrals and EP routes to diagnosis differ across regions in England.

AIM

To investigate routes to diagnosis of CCA over time, regional variation and influencing factors.

METHODS

We linked patient records from the National Cancer Registration Dataset to Hospital Episode Statistics, Cancer Waiting Times and Cancer Screening Programme datasets to define routes to diagnosis and certain patient characteristics for patients diagnosed 2006-2017 in England. We used linear probability models to investigate geographic variation by assessing the proportions of patients diagnosed TWW referral or EP across Cancer Alliances in England, adjusting for potential confounders. Correlation between the proportion of people diagnosed by TWW referral and EP was investigated with Spearman's correlation coefficient.

RESULTS

Of 23632 patients diagnosed between 2006-2017 in England, the most common route to diagnosis was EP (49.6%). Non-TWW GP referrals accounted for 20.5% of diagnosis routes, 13.8% were diagnosed by TWW referral, and the remainder 16.2% were diagnosed an 'other' or Unknown route. The proportion diagnosed a TWW referral doubled between 2006-2017 rising from 9.9% to 19.8%, conversely EP diagnosis route declined, falling from 51.3% to 46.0%. Statistically significant variation in both the TWW referral and EP proportions was found across Cancer Alliances. Age, presence of comorbidity and underlying liver disease were independently associated with both a lower proportion of patients diagnosed TWW referral, and a higher proportion diagnosed by EP after adjusting for other potential confounders.

CONCLUSION

There is significant geographic and socio-demographic variation in routes to diagnosis of CCA in England. Knowledge sharing of best practice may improve diagnostic pathways and reduce unwarranted variation.

摘要

背景

胆管癌(CCA)的发病率正在上升,整体预后仍然很差。CCA 死亡率高的原因包括大多数患者就诊时已处于晚期,此时已无法进行根治性治疗,以及晚期疾病的系统治疗反应不佳。就诊时间晚是改善预后的一大障碍,且常与紧急就诊(EP)相关。通过全科医生(GP)的两周就诊(TWW)转诊,可能更早诊断出该病。我们假设 TWW 转诊和 EP 诊断途径在英格兰不同地区存在差异。

目的

研究 CCA 的诊断途径随时间的变化、区域差异及其影响因素。

方法

我们将国家癌症登记数据集的患者记录与医院住院统计、癌症等待时间和癌症筛查计划数据集相链接,以确定 2006-2017 年在英格兰诊断出 CCA 的患者的诊断途径和某些患者特征。我们使用线性概率模型通过评估英格兰各癌症联盟中通过 TWW 转诊或 EP 诊断的患者比例来评估地理差异,同时调整潜在混杂因素。使用 Spearman 相关系数来研究通过 TWW 转诊和 EP 诊断的患者比例之间的相关性。

结果

在英格兰 2006-2017 年期间诊断出的 23632 例患者中,最常见的诊断途径是 EP(49.6%)。非 TWW 的 GP 转诊占诊断途径的 20.5%,13.8%通过 TWW 转诊诊断,其余 16.2%通过“其他”或未知途径诊断。2006-2017 年期间,通过 TWW 转诊诊断的患者比例增加了一倍,从 9.9%增加到 19.8%,相反 EP 诊断途径的比例下降,从 51.3%下降到 46.0%。在癌症联盟之间,TWW 转诊和 EP 比例均存在统计学显著差异。年龄、合并症和潜在肝脏疾病与通过 TWW 转诊的患者比例较低,以及 EP 诊断的患者比例较高均独立相关,且在调整其他潜在混杂因素后,结果仍然成立。

结论

在英格兰,CCA 的诊断途径存在显著的地理和社会人口统计学差异。最佳实践知识共享可能会改善诊断途径并减少不必要的差异。

相似文献

1
Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017.2006 年至 2017 年英格兰胆管癌诊断途径的地域差异。
World J Gastroenterol. 2023 Jun 28;29(24):3825-3842. doi: 10.3748/wjg.v29.i24.3825.
2
Cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to Diagnosis data, 2006-2015.英国急诊医生转诊或急症就诊后癌症诊断:2006-2015 年诊断途径数据中的决定因素和时间趋势。
Br J Gen Pract. 2019 Sep 26;69(687):e724-e730. doi: 10.3399/bjgp19X705473. Print 2019 Oct.
3
Cohort study to assess geographical variation in cholangiocarcinoma treatment in England.评估英国胆管癌治疗地理差异的队列研究。
World J Gastrointest Oncol. 2023 Dec 15;15(12):2077-2092. doi: 10.4251/wjgo.v15.i12.2077.
4
Epidemiology of cholangiocarcinoma.胆管癌的流行病学
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16.
5
Inter general practice variability in use of referral guidelines for colorectal cancer.全科医疗中结直肠癌转诊指南使用的差异
Colorectal Dis. 2007 Oct;9(8):731-5. doi: 10.1111/j.1463-1318.2006.01201.x.
6
Cholangiocarcinoma across England: Temporal changes in incidence, survival and routes to diagnosis by region and level of socioeconomic deprivation.全英格兰的胆管癌:发病率、生存率以及按地区和社会经济剥夺程度划分的诊断途径的时间变化。
JHEP Rep. 2023 Dec 15;6(3):100983. doi: 10.1016/j.jhepr.2023.100983. eCollection 2024 Mar.
7
Cholangiocarcinoma.胆管癌。
Pathologica. 2021 Jun;113(3):158-169. doi: 10.32074/1591-951X-252.
8
Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis.儿童和青少年胆管癌:文献综述及监测、流行病学和最终结果计划数据库分析
J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):e12-e18. doi: 10.1097/MPG.0000000000001749.
9
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.欧洲胆管癌全景:ENSCCA 注册中心的诊断、预后和治疗见解。
J Hepatol. 2022 May;76(5):1109-1121. doi: 10.1016/j.jhep.2021.12.010. Epub 2022 Feb 12.
10
Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality.肝细胞癌患者的诊断途径:预测因素及其与治疗和死亡率的关联。
Br J Cancer. 2024 Jun;130(10):1697-1708. doi: 10.1038/s41416-024-02645-3. Epub 2024 Mar 18.

引用本文的文献

1
Understanding Cholangiocarcinoma-perspectives from three European advocacy groups.了解胆管癌——来自三个欧洲倡导组织的观点。
Lancet Reg Health Eur. 2025 Feb 19;50:101239. doi: 10.1016/j.lanepe.2025.101239. eCollection 2025 Mar.
2
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies.绘制欧洲胆管癌的全景图:挑战与争议
Lancet Reg Health Eur. 2025 Feb 19;50:101171. doi: 10.1016/j.lanepe.2024.101171. eCollection 2025 Mar.
3
Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic.

本文引用的文献

1
Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial.基于游离DNA的无症状筛查人群多癌早期检测试验(NHS-Galleri):一项实用、前瞻性随机对照试验的设计
Cancers (Basel). 2022 Oct 1;14(19):4818. doi: 10.3390/cancers14194818.
2
Cholangiocarcinoma.胆管癌。
Nat Rev Dis Primers. 2021 Sep 9;7(1):65. doi: 10.1038/s41572-021-00300-2.
3
Which patients miss appointments with general practice and the reasons why: a systematic review.
从集中在苏格兰西部的胆道肿瘤临床中心的真实数据中获得的临床管理见解。
BMC Cancer. 2024 May 16;24(1):597. doi: 10.1186/s12885-024-12279-6.
哪些患者会错过全科医疗预约及其原因:一项系统综述。
Br J Gen Pract. 2021 May 27;71(707):e406-e412. doi: 10.3399/BJGP.2020.1017. Print 2021 Jun.
4
The effectiveness of the Guy's Rapid Diagnostic Clinic (RDC) in detecting cancer and serious conditions in vague symptom patients.盖伊快速诊断诊所(RDC)在诊断模糊症状患者的癌症和严重疾病方面的效果。
Br J Cancer. 2021 Mar;124(6):1079-1087. doi: 10.1038/s41416-020-01207-7. Epub 2021 Jan 5.
5
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020:机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
6
Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study.利用英格兰住院电子健康记录验证算法,以确定肝细胞癌患者中肝硬化的存在和严重程度:一项观察性研究。
BMJ Open. 2019 Jul 9;9(7):e028571. doi: 10.1136/bmjopen-2018-028571.
7
Cancer risk, screening and surveillance in primary sclerosing cholangitis.原发性硬化性胆管炎的癌症风险、筛查与监测
Minerva Gastroenterol Dietol. 2019 Sep;65(3):214-228. doi: 10.23736/S1121-421X.19.02586-8. Epub 2019 Jun 19.
8
Data Resource Profile: National Cancer Registration Dataset in England.数据资源简介:英格兰国家癌症登记数据集
Int J Epidemiol. 2020 Feb 1;49(1):16-16h. doi: 10.1093/ije/dyz076.
9
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.全球肝内和肝外胆管癌死亡率的趋势。
J Hepatol. 2019 Jul;71(1):104-114. doi: 10.1016/j.jhep.2019.03.013. Epub 2019 Mar 23.
10
When size matters: advantages of weighted effect coding in observational studies.当样本量起作用时:观察性研究中加权效应编码的优势
Int J Public Health. 2017 Jan;62(1):163-167. doi: 10.1007/s00038-016-0901-1. Epub 2016 Oct 28.